News stories about Envision Healthcare (NYSE:EVHC) have trended somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies positive and negative news coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Envision Healthcare earned a daily sentiment score of 0.03 on Accern’s scale. Accern also gave news headlines about the company an impact score of 45.5647581890034 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.
These are some of the headlines that may have effected Accern Sentiment Analysis’s scoring:
- EVHC Crosses Above Average Analyst Target (nasdaq.com)
- Facts About In Play Stocks – Envision Healthcare Corporation (NYSE:EVHC) (nasdaqjournal.com)
- Notes: NHI pays $17M for Michigan centers (nashvillepost.com)
- Surprising Stocks: Envision Healthcare Corporation (NYSE:EVHC), My Size, Inc. (NASDAQ:MYSZ), Royal Caribbean … (thestreetpoint.com)
- NYSE:EVHC Investor Alert: Investigation of Takeover of Envision Healthcare Corporation (digitaljournal.com)
Shares of Envision Healthcare opened at $44.68 on Friday, Marketbeat Ratings reports. The company has a quick ratio of 2.25, a current ratio of 2.27 and a debt-to-equity ratio of 0.65. The stock has a market cap of $5.42 billion, a P/E ratio of 18.02, a PEG ratio of 1.10 and a beta of 0.46. Envision Healthcare has a 12-month low of $23.77 and a 12-month high of $64.00.
Envision Healthcare (NYSE:EVHC) last posted its quarterly earnings data on Monday, May 7th. The company reported $0.71 earnings per share for the quarter, beating the consensus estimate of $0.64 by $0.07. The firm had revenue of $2.08 billion during the quarter, compared to analysts’ expectations of $2.02 billion. Envision Healthcare had a net margin of 1.41% and a return on equity of 4.59%. The company’s quarterly revenue was up 10.6% compared to the same quarter last year. During the same quarter last year, the company posted $0.77 EPS. equities research analysts forecast that Envision Healthcare will post 3.41 EPS for the current fiscal year.
A number of equities analysts have recently issued reports on the stock. William Blair cut shares of Envision Healthcare from an “outperform” rating to a “market perform” rating in a research note on Monday, June 11th. Robert W. Baird set a $50.00 price objective on shares of Envision Healthcare and gave the company a “buy” rating in a research note on Wednesday, April 11th. Jefferies Financial Group set a $46.00 target price on shares of Envision Healthcare and gave the stock a “buy” rating in a research report on Wednesday, April 11th. Canaccord Genuity increased their target price on shares of Envision Healthcare from $46.00 to $48.00 and gave the stock a “buy” rating in a research report on Wednesday, May 9th. Finally, Zacks Investment Research upgraded shares of Envision Healthcare from a “hold” rating to a “buy” rating and set a $46.00 target price for the company in a research report on Friday, May 11th. Two research analysts have rated the stock with a sell rating, twelve have issued a hold rating and five have given a buy rating to the stock. Envision Healthcare has a consensus rating of “Hold” and a consensus target price of $41.59.
Envision Healthcare Company Profile
Envision Healthcare Corporation, through its subsidiaries, provides various healthcare services in the United States. The company operates through two segments, Physician Services and Ambulatory Services. As of December 31, 2017, its physician-led services encompassed providers at approximately 1,800 clinical departments at healthcare facilities in 45 states and the District of Columbia that include emergency department and hospitalist, anesthesiology, radiology/tele-radiology, and children's services.
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.